Formulation for spray-drying large porous particles
View Patent ↗Particles having a tap density less than about 0.4 g/cm3 are formed by spray drying from a colloidal solution including a carboxylic acid or salt thereof, a phospholipid, a divalent salt and a solvent such as an aqueous-organic solvent. The colloidal solution can also include a therapeutic, prophylactic or diagnostic agent. Preferred carboxylic acids include at least two carboxyl groups. Preferred phospholipids include phosphatidylcholines, phosphatidylethanolamines, phosphatidylglycerols, phophstidylserines, phosphatidylinositols and combinations thereof. The particles are suitable for pulmonary delivery.
1. A method of preparing particles having a tap density less than about 0.4 g/cm 3 comprising:
(a) forming a mixture including: a therapeutic, prophylactic or diagnostic agent, or any combination thereof, at least 10% weight of a hydroxydicarboxylic acid and/or hydroxytricarboxylic acid or a salt thereof, a phospholipid, a salt comprising at least one multivalent cation or anion and a solvent; and
(b) spray-drying said mixture to produce particles having a tap density less than about 0.4 g/cm 3 and an aerodynamic diameter between 1 and 5 microns.
2. The method of claim 1 , wherein the particles have a median geometric diameter of between about 5 microns and about 30 microns.
3. The method of claim 1 , wherein the particles have an aerodynamic diameter of between about 1 and about 3 microns.
4. The method of claim 1 , wherein the particles have an aerodynamic diameter of between about 3 and about 5 microns.
5. The method of claim 1 , wherein the hydroxydicarboxylic acid and/or hydroxytricarboxylic acid is citric acid, or a salt thereof.
6. The method of claim 1 , wherein the phospholipid is endogenous to the lung.
7. The method of claim 1 , wherein the phospholipid is selected from the group consisting of phosphatidylcholines, phosphatidyletanolamines, phosphatidylglycerols, phosphatidylserines, phosphatidylinositols and combinations thereof.
8. The method of claim 1 , wherein the phospholipid is present in the mixture in an amount of at least about 20% weight.
9. The method of claim 1 , wherein the salt comprising at least one multivalent cation or anion is a salt of an alkaline earth metal.
10. The method of claim 1 , wherein the salt comprising at least one multivalent cation or anion is a chloride.
11. The method of claim 1 , wherein the salt comprising at least one multivalent cation or anion is calcium chloride.
12. The method of claim 1 , wherein the salt comprising at least one multivalent cation or anion in present in the mixture in an amount of at least about 5% weight.
13. The method of claim 1 , wherein the therapeutic, prophylactic or diagnostic agent is albuterol.
14. The method of claim 1 , wherein the therapeutic, prophylactic or diagnostic agent is present in the mixture in an amount between about less than 1% and about 40% weight.
15. The method of claim 1 , wherein the solvent includes an organic solvent.
16. The method of claim 1 , wherein the solvent includes an aqueous organic co-solvent.
17. The method of claim 1 , wherein the mixture is a colloidal solution.